Association between matrix metalloproteinase 9 polymorphisms and breast cancer risk: An updated meta-analysis and trial sequential analysis

被引:9
作者
Xu, Tai [1 ,2 ]
Zhang, Siming [1 ]
Qiu, Dongqin [1 ]
Li, Xiaoyuan [1 ]
Fan, Yuanlin [1 ]
机构
[1] Meizhou Peoples Hosp, Dept Breast Surg, 63 Huangtang Rd, Meizhou 514000, Guangdong, Peoples R China
[2] Meizhou Peoples Hosp, Guangdong Prov Key Lab Precis Med & Clin Translat, Meizhou 514000, Guangdong, Peoples R China
关键词
Breast cancer; Matrix metalloproteinase 9; Polymorphism; Meta-analysis; MATRIX METALLOPROTEINASES; GENETIC POLYMORPHISMS; PROMOTER REGIONS; GELATINASE-B; MMP-9; STATISTICS; EXPRESSION; SUSCEPTIBILITY; PROGRESSION; SURVIVAL;
D O I
10.1016/j.gene.2020.144972
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Numerous studies have sought associations between matrix metalloproteinase 9 (MMP-9) polymorphisms and breast cancer risk. However, these studies have yielded conflicting results. Hence, we performed an updated meta-analysis to clarify the effects of four MMP-9 gene polymorphisms (rs3918242, rs2250889, rs3787268, and rs17576) on breast cancer risk. Methods: A comprehensive literature search for eligible studies was conducted in five electronic databases, including PubMed, Embase and Web of Science, up to March 1, 2020. Summary odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of associations in random-effects models. For the reduction of type I errors, a trial sequential analysis (TSA) was performed. Results: Twenty-one studies (8813 breast cancer cases and 9323 controls) were included in the quantitative analysis. For rs3918242, the overall ORs were significant under allelic comparison (OR (A vs. G) = 1.34; 95% CI 1.03, 1.74, P = 0.028) and the recessive genetic model (OR (AA vs. GG+GA) = 1.40; 95% CI 1.06, 1.84, P = 0.016). For rs2250889, the ORs were significant under homozygote comparison (OR (GG vs. CC) = 2.57; 95% CI 1.22, 5.42, P = 0.013), heterozygote comparison (OR (GC vs. CC) = 2.48; 95% CI 1.17, 5.23, P = 0.018), and the dominant genetic model (OR (GG+GC vs. CC) = 2.53; 95% CI 1.23, 5.20, P = 0.012). No associations were observed for rs3787268 or rs17576. The subgroup analyses indicated that the risk effect of the rs3918242 A allele was observed only among Asians. TSA showed that the findings for rs3918242, rs3787268, and rs17576 were robust, but many more patients are needed before definitive conclusions can be made for rs2250889. Conclusion: Our meta-analysis suggests that MMP-9 rs3918242, but not rs3787268 and rs17576 polymorphisms, may be risk factors for breast cancer. The effect of rs2250889 needs further confirmation with a larger sample size.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] ASSOCIATION OF MTHFR A1298C POLYMORPHISM WITH BREAST CANCER AND/OR OVARIAN CANCER RISK: AN UPDATED META-ANALYSIS
    Liu, Wei
    Li, Yi
    Li, Rui
    Han, Xiao
    Ma, Ying
    Liu, Bin
    Kong, Xiangzhen
    AFRICAN JOURNAL OF TRADITIONAL COMPLEMENTARY AND ALTERNATIVE MEDICINES, 2016, 13 (05) : 72 - 86
  • [32] Association between OPG polymorphisms and osteoporosis risk: An updated meta-analysis
    Han, Xu
    Zheng, Lai
    Mu, Yi-Yang
    Li, Hong-Zhuo
    He, Xiao-Feng
    FRONTIERS IN GENETICS, 2022, 13
  • [33] Effect of matrix metalloproteinase promoter polymorphisms on endometriosis and adenomyosis risk: evidence from a meta-analysis
    Ye, Hui
    He, Yazhou
    Wang, Jiarong
    Song, Tiange
    Lan, Zhu
    Zhao, Yiqi
    Xi, Mingrong
    JOURNAL OF GENETICS, 2016, 95 (03) : 611 - 619
  • [34] Association between the STK15 polymorphisms and risk of cancer: a meta-analysis
    Qin, Jun
    He, Xiao-Feng
    Wei, Wu
    Liu, Zhi-Zhong
    Xie, Jian-Jun
    Wang, Wei
    Du, Ya-Ping
    Chen, Yu
    Si, Hui-Qiang
    MOLECULAR GENETICS AND GENOMICS, 2015, 290 (01) : 97 - 114
  • [35] Association between STAT3 polymorphisms and cancer risk: a meta-analysis
    Yan, Ruicheng
    Lin, Fusheng
    Hu, Chao
    Tong, Shilun
    MOLECULAR GENETICS AND GENOMICS, 2015, 290 (06) : 2261 - 2270
  • [36] Association between TNF-α polymorphisms and cervical cancer risk: a meta-analysis
    Liu, Li
    Yang, Xi
    Chen, Xiaojun
    Kan, Tinjing
    Shen, Yan
    Chen, Zengyan
    Hu, Zhibin
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (03) : 2683 - 2688
  • [37] Meta-analysis of association of the matrix metalloproteinase 2 (-735 C/T) polymorphism with cancer risk
    Kim, Su Kang
    Kang, Sang Wook
    Park, Hae Jeong
    Ban, Ju Yeon
    Oh, Chung-Hun
    Chung, Joo-Ho
    Oh, In-Hwan
    Cho, Kyu Bong
    Park, Min-Su
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (10): : 17096 - 17101
  • [38] Associations Between Three CTLA-4 Polymorphisms and Hashimoto's Thyroiditis Risk: An Updated Meta-Analysis with Trial Sequential Analysis
    Hu, Yifang
    Xu, Kuanfeng
    Jiang, Lin
    Zhang, Lijuan
    Shi, He
    Cui, Dai
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2018, 22 (04) : 224 - 236
  • [39] The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis
    Gao, Lin-Bo
    Bai, Peng
    Pan, Xin-Min
    Jia, Jing
    Li, Li-Juan
    Liang, Wei-Bo
    Tang, Ming
    Zhang, Lu-Shun
    Wei, Yong-Gang
    Zhang, Lin
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (02) : 571 - 574
  • [40] Lack of association between interferon gamma +874 T/A polymorphism and cancer risk: an updated meta-analysis
    Ge, Yu-Zheng
    Wang, Yi-Dan
    Xu, Zheng
    Xu, Lu-Wei
    Wang, Ya-Ping
    Gu, Mao-Hong
    Ding, Ai-Xing
    Zhu, Xian-Bo
    Wu, Ran
    Li, Wen-Cheng
    Xu, You-Di
    Jia, Rui-Peng
    TUMOR BIOLOGY, 2014, 35 (07) : 6405 - 6414